Nanozyme: a rising star for cancer therapy
Nanoscale · 2023
DOI: 10.1039/d3nr01976d ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanoscale, 2023. Verfasst von Qingqing Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Superlight Materials and Surface Technology, Ministry of Education, College of Materials Science and Chemical Engineering, Harbin E…. Hauptthemen laut MEDLINE: Nanostructures, Neoplasms. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.
Abstract (Originalsprache)
Tumor therapy by nanozymes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Superlight Materials and Surface Technology, Ministry of Education, College of Materials Science and Chemical Engineering, Harbin Engineering University, Harbin 150001, P. R. China. wangqingqing@hrbeu.…
- School of Medicine and Health, Harbin Institute of Technology, Harbin 150080, China. shaoqinliu@hit.edu.cn.
Förderung
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Wang, Q., Liu, J., He, L., Liu, S., & Yang, P. (2023). Nanozyme: a rising star for cancer therapy. Nanoscale. https://doi.org/10.1039/d3nr01976d
Vancouver
Wang Q, Liu J, He L, Liu S, Yang P. Nanozyme: a rising star for cancer therapy. Nanoscale. 2023. doi:10.1039/d3nr01976d
BibTeX
@article{Wang2023,
author = {Wang, Qingqing and Liu, Jing and He, Liangcan and Liu, Shaoqin and Yang, Piaoping},
title = {Nanozyme: a rising star for cancer therapy},
journal = {Nanoscale},
year = {2023},
doi = {10.1039/d3nr01976d}
}
EUVIMED